Fluconazole bioequivalence study: quantification by tandem mass spectrometry (1999)
Source: Therapeutic Drug Monitoring. Unidade: ICB
Assunto: FARMACOLOGIA
ABNT
MORAES, L A et al. Fluconazole bioequivalence study: quantification by tandem mass spectrometry. Therapeutic Drug Monitoring, v. 21, n. 2, p. 200-207, 1999Tradução . . Acesso em: 04 set. 2024.APA
Moraes, L. A., Lerner, F. E., Moraes, M. E., Corso, G., & De Nucci, G. (1999). Fluconazole bioequivalence study: quantification by tandem mass spectrometry. Therapeutic Drug Monitoring, 21( 2), 200-207.NLM
Moraes LA, Lerner FE, Moraes ME, Corso G, De Nucci G. Fluconazole bioequivalence study: quantification by tandem mass spectrometry. Therapeutic Drug Monitoring. 1999 ; 21( 2): 200-207.[citado 2024 set. 04 ]Vancouver
Moraes LA, Lerner FE, Moraes ME, Corso G, De Nucci G. Fluconazole bioequivalence study: quantification by tandem mass spectrometry. Therapeutic Drug Monitoring. 1999 ; 21( 2): 200-207.[citado 2024 set. 04 ]